We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39.9B
AUM Growth
+$1.35B
Cap. Flow
-$64.9M
Cap. Flow %
-0.16%
Top 10 Hldgs %
13.16%
Holding
2,910
New
487
Increased
855
Reduced
1,229
Closed
318

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$379M
2
NVDA icon
NVIDIA
NVDA
+$346M
3
ATVI
Activision Blizzard
ATVI
+$343M
4
PYPL icon
PayPal
PYPL
+$328M
5
AMD icon
Advanced Micro Devices
AMD
+$279M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$461M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$406M
3
SNAP icon
Snap
SNAP
+$379M
4
ADI icon
Analog Devices
ADI
+$283M
5
T icon
AT&T
T
+$280M

Sector Composition

Rank Sector Weight
1 Technology 26.09%
2 Healthcare 22.86%
3 Industrials 9.26%
4 Financials 8.76%
5 Consumer Discretionary 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRR
2526
DELISTED
Star Equity Holdings
STRR
$28K ﹤0.01%
+2,200
New +$28.6K
XIN
2527
DELISTED
Xinyuan Real Estate
XIN
$28K ﹤0.01%
4,460
+2,080
+87% +$21.4K
ASPU
2528
DELISTED
ASPEN GROUP, INC.
ASPU
$28K ﹤0.01%
+11,900
New +$48.7K
VIVE
2529
DELISTED
VIVEVE MED INC
VIVE
$28K ﹤0.01%
+24,300
New +$44.6K
ZVO
2530
DELISTED
Zovio Inc. Common Stock
ZVO
$28K ﹤0.01%
22,000
-14,800
-40% -$26K
IBIO icon
2531
iBio
IBIO
$69.5M
$27K ﹤0.01%
+98
New +$37.4K
ACGN
2532
DELISTED
Aceragen Inc
ACGN
$26K ﹤0.01%
2,729
-44,134
-94% -$592K
GNCA
2533
DELISTED
Genocea Biosciences, Inc.
GNCA
$26K ﹤0.01%
22,677
-119,800
-84% -$179K
AIHS icon
2534
Senmiao Technology Ltd
AIHS
$20.5M
$25K ﹤0.01%
677
-16
-2% -$928
GNPX icon
2535
Genprex
GNPX
$2.93M
0
NCEL
2536
NewcelX Ltd
NCEL
$18.5M
$25K ﹤0.01%
57
-11
-16% -$8.42K
ONCT
2537
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$25K ﹤0.01%
540
-5,690
-91% -$383K
AYTU icon
2538
AYTU BioPharma
AYTU
$22.9M
$24K ﹤0.01%
+872
New +$37.7K
IPDN icon
2539
Professional Diversity Network
IPDN
$4.23M
$24K ﹤0.01%
+1,240
New +$30K
MREO
2540
Mereo BioPharma
MREO
$50.4M
$24K ﹤0.01%
+15,100
New +$30.2K
RETO icon
2541
ReTo Eco-Solutions
RETO
$22.9M
0
VGFC
2542
DELISTED
The Very Good Food Company
VGFC
$23K ﹤0.01%
+31,700
New +$40.5K
JFU
2543
9F Inc
JFU
$23.7M
$22K ﹤0.01%
+1,005
New +$27.7K
AEHL icon
2544
Antelope Enterprise Holdings
AEHL
$8.67M
$21K ﹤0.01%
+5
New +$29K
MITO
2545
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$21K ﹤0.01%
25,200
-200
-0.8% -$209
MBII
2546
DELISTED
Marrone Bio Innovations, Inc.
MBII
$21K ﹤0.01%
29,500
+7,400
+33% +$5.99K
CTEK
2547
DELISTED
CynergisTek, Inc.
CTEK
$20K ﹤0.01%
14,100
-200
-1% -$319
SONM icon
2548
DNA X Inc
SONM
$4.76M
$19K ﹤0.01%
+117
New +$35.5K
BLNE
2549
Beeline Holdings
BLNE
$28.8M
$19K ﹤0.01%
53
-5
-9% -$2.3K
IZEA icon
2550
IZEA Worldwide
IZEA
$59M
$17K ﹤0.01%
+3,150
New +$22.8K

Similar funds

Two Sigma Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Two Sigma Advisers held 2,910 positions worth $39.9B, up 3.5% from $38.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Two Sigma Advisers's Q4 2021 filing shows 487 new, 855 increased, 1,229 reduced and 318 closed positions. Its largest new stake was NVIDIA: 12,564,000 shares worth $370M. The largest sale was Qualcomm, an estimated $461M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Two Sigma Advisers's largest Q4 2021 buy was NVIDIA: 12,564,000 shares worth $370M.
  • Two Sigma Advisers added most to Tesla in Q4 2021, an estimated $379M increase.
  • Two Sigma Advisers's biggest Q4 2021 reduction was Qualcomm, cutting an estimated $461M.
  • Two Sigma Advisers fully exited Snap in Q4 2021, selling an estimated $379M.
  • Two Sigma Advisers's ten largest holdings make up 13% of its $39.9B portfolio in Q4 2021.
  • Two Sigma Advisers opened 487 new positions and closed 318 in Q4 2021.
  • Two Sigma Advisers's portfolio value rose 3.5% quarter-over-quarter to $39.9B.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.